Home / Market News / $NDRA

$NDRA news and market catalysts

The 2 most recent market catalysts affecting $NDRA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

2 catalysts 2 high impact 1 bullish 0 bearish Healthcare Technology
Nov 17, 2026 Corporate Catalyst Neutral Impact 85
ENDRA Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business Update
ENDRA Life Sciences reported a Q3 2026 net loss of $1.5 million, a marginal improvement from the prior year. More significantly, the company provided an update on its proposed merg…
Aug 17, 2026 Corporate Catalyst Bullish Impact 92
ENDRA Life Sciences Q2 EPS $0.06 Beats $(0.84) Estimate
ENDRA Life Sciences announced Q2 earnings per share of $0.06, which dramatically surpassed the consensus estimate of $(0.84). This represents a 107.14% beat and a 103.51% improveme…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.